Molina Healthcare, Inc. Files Definitive Proxy Statement

Ticker: MOH · Form: DEF 14A · Filed: Mar 21, 2024 · CIK: 1179929

Molina Healthcare, Inc. DEF 14A Filing Summary
FieldDetail
CompanyMolina Healthcare, Inc. (MOH)
Form TypeDEF 14A
Filed DateMar 21, 2024
Risk Levellow
Pages15
Reading Time18 min
Sentimentneutral

Sentiment: neutral

Topics: Proxy Statement, DEF 14A, Molina Healthcare, SEC Filing, Corporate Governance

TL;DR

<b>Molina Healthcare, Inc. has filed its Definitive Proxy Statement for the 2023 fiscal year.</b>

AI Summary

MOLINA HEALTHCARE, INC. (MOH) filed a Proxy Statement (DEF 14A) with the SEC on March 21, 2024. Molina Healthcare, Inc. filed a Definitive Proxy Statement (DEF 14A) on March 21, 2024. The filing covers the period from January 1, 2023, to December 31, 2023. The company's principal executive offices are located at 200 Oceangate, Suite 100, Long Beach, CA 90802. The filing is made pursuant to Section 14(a) of the Securities Exchange Act of 1934. No fee was required for this filing.

Why It Matters

For investors and stakeholders tracking MOLINA HEALTHCARE, INC., this filing contains several important signals. This filing is a standard requirement for publicly traded companies to inform shareholders about matters to be voted on at meetings, including executive compensation and director elections. The DEF 14A provides detailed information on executive compensation, stock awards, and other corporate governance matters, which are crucial for investor decision-making.

Risk Assessment

Risk Level: low — MOLINA HEALTHCARE, INC. shows low risk based on this filing. The filing is a routine proxy statement and does not contain new financial performance data or strategic changes that would inherently increase risk.

Analyst Insight

Review the executive compensation details and any shareholder proposals within the proxy statement to understand potential impacts on corporate governance and shareholder value.

Key Numbers

  • 2024-03-21 — Filing Date (DEF 14A filing date)
  • 2023-12-31 — Fiscal Year End (Molina Healthcare's fiscal year end)
  • 2023-01-01 — Reporting Period Start (Reporting period start date)
  • 2023-12-31 — Reporting Period End (Reporting period end date)

Key Players & Entities

  • MOLINA HEALTHCARE, INC. (company) — Registrant Name
  • 200 OCEANGATE, SUITE 100 (location) — Business Address
  • LONG BEACH (location) — Business Address City
  • CA (location) — Business Address State
  • 90802 (location) — Business Address Zip
  • 5624353666 (phone) — Business Phone

FAQ

When did MOLINA HEALTHCARE, INC. file this DEF 14A?

MOLINA HEALTHCARE, INC. filed this Proxy Statement (DEF 14A) with the SEC on March 21, 2024.

What is a DEF 14A filing?

A DEF 14A is a definitive proxy statement sent to shareholders before annual meetings, covering executive compensation, board nominations, and shareholder votes. This particular DEF 14A was filed by MOLINA HEALTHCARE, INC. (MOH).

Where can I read the original DEF 14A filing from MOLINA HEALTHCARE, INC.?

You can access the original filing directly on the SEC's EDGAR system. The filing is publicly available and includes all exhibits and attachments submitted by MOLINA HEALTHCARE, INC..

What are the key takeaways from MOLINA HEALTHCARE, INC.'s DEF 14A?

MOLINA HEALTHCARE, INC. filed this DEF 14A on March 21, 2024. Key takeaways: Molina Healthcare, Inc. filed a Definitive Proxy Statement (DEF 14A) on March 21, 2024.. The filing covers the period from January 1, 2023, to December 31, 2023.. The company's principal executive offices are located at 200 Oceangate, Suite 100, Long Beach, CA 90802..

Is MOLINA HEALTHCARE, INC. a risky investment based on this filing?

Based on this DEF 14A, MOLINA HEALTHCARE, INC. presents a relatively low-risk profile. The filing is a routine proxy statement and does not contain new financial performance data or strategic changes that would inherently increase risk.

What should investors do after reading MOLINA HEALTHCARE, INC.'s DEF 14A?

Review the executive compensation details and any shareholder proposals within the proxy statement to understand potential impacts on corporate governance and shareholder value. The overall sentiment from this filing is neutral.

How does MOLINA HEALTHCARE, INC. compare to its industry peers?

Molina Healthcare, Inc. operates within the hospital and medical service plans industry, providing health plans and related services.

Are there regulatory concerns for MOLINA HEALTHCARE, INC.?

The filing is made under the Securities Exchange Act of 1934, specifically Section 14(a), which governs the solicitation of proxies.

Industry Context

Molina Healthcare, Inc. operates within the hospital and medical service plans industry, providing health plans and related services.

Regulatory Implications

The filing is made under the Securities Exchange Act of 1934, specifically Section 14(a), which governs the solicitation of proxies.

What Investors Should Do

  1. Review the executive compensation table for details on CEO and other named executive officer pay.
  2. Examine any shareholder proposals and management's recommendations.
  3. Note the voting procedures and record date for the upcoming shareholder meeting.

Year-Over-Year Comparison

This is a DEF 14A filing, which is a standard annual disclosure for public companies, not a comparison to a prior filing type.

Filing Stats: 4,508 words · 18 min read · ~15 pages · Grade level 13.2 · Accepted 2024-03-21 16:18:32

Filing Documents

Executive Compensation

Executive Compensation 30 Compensation Discussion and Analysis 30 Compensation Committee Report 42 Compensation Tables 43 2023 Summary Compensation Table 43 2023 All Other Compensation Table 44 2023 Grants of Plan-Based Awards Table 45 2023 Outstanding Equity Awards at Fiscal Year End Table 46 Outstanding Equity Awards Vesting Schedule Table 47 2023 Option Exercises and Stock Vested Table 48 Non-Qualified Deferred Compensation for 2023 49 Potential Payments Upon Change in Control or Termination 49 CEO Pay Ratio 53 Pay Versus Performance 54 Compensation Committee Interlocks and Insider Participation 59 Fiscal Year 2024 Compensation 60 PROPOSAL 3 - Ratification of the Appointment of Independent Registered Public Accounting Firm 63 Audit Committee Report 64 Audit Committee's Evaluation and Oversight of Independent Auditors 65 Fees Paid to Independent Registered Public Accounting Firm 67 PROPOSAL 4 - Shareholder Proposa l R e g a r d i n g S imple Majority Vot ing 68

Security Ownership of Certain Beneficial Owners and Management

Security Ownership of Certain Beneficial Owners and Management 70

Security Ownership of Management

Security Ownership of Management 70

Security Ownership of Principal Stockholders

Security Ownership of Principal Stockholders 71 Securities Authorized for Issuance Under Equity Compensation Plans 71 Management Analysis of Material Adverse Effects of Compensation Plans 72 Householding 72 Others Matters 72 Questions and Answers About our Annual Meeting 73 Proxy Card & Instructions 78 Proxy Statement Summary This proxy statement is furnished in connection with the solicitation of proxies on behalf of the Board of Directors of Molina Healthcare, Inc. ("Board" or "Board of Directors") for the annual meeting of stockholders to be held on Wednesday, May 1, 2024, at 10:00 a.m. Eastern time, and is being mailed or transmitted on or about March 21, 2024 to the Company's stockholders of record as of March 8, 2024. Please review this proxy statement in its entirety and the Company's 2023 Annual Report on Form 10-K for the year ended December 31, 2023 ("Annual Report") before voting. In this proxy statement, we may refer to Molina Healthcare, Inc. as the "Company," "Molina Healthcare," "our," or "we". Meeting Details DATE AND TIME LOCATION WHO CAN VOTE Wednesday, May 1, 2024 10:00 a.m., Eastern time Meeting will be held live via the internet at www.virtualshareholdermeeting.com/MOH2024 Stockholders of record on the close of business on March 8, 2024 are entitled to vote at the 2024 Annual Meeting. Ways to Vote BY INTERNET BY TOLL-FREE TELEPHONE BY MAIL During the Annual Meeting or prior to the meeting at www.proxyvote.com 1-800-690-6903 Follow instructions on your proxy card Matters for Stockholder Voting At this year's annual meeting, we are asking our stockholders to vote on the following matters: Proposal Board Vote Recommendation 1 To elect the nine directors named in this proxy statement to hold office until the 2025 annual meeting. FOR 2 To consider and approve, on a non-binding, advisory basis, the compensation of our named executive officers. FOR 3 To ratify the appointment of Ernst & Young LLP as o

View Full Filing

View this DEF 14A filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.